Jankowiak Carsten, Ludwig Diether
Medizinische Klinik I, Bereich Gastroenterologie, Universitätsklinikum Schleswig-Holstein Campus Lübeck, Ratzeburger Allee 160, Lübeck.
Med Klin (Munich). 2008 Jun 15;103(6):413-22; quiz 423-4. doi: 10.1007/s00063-008-1061-8.
Celiac disease and lactose intolerance are both relatively frequent diseases with symptoms occurring after ingestion of certain food components. In celiac disease wheat gluten and related proteins of other cereals induce an inflammatory disease of the small intestine in predisposed individuals, leading to gastrointestinal and extraintestinal symptoms. Moreover, there is an association with many other diseases and besides classic symptoms (diarrhea, weight loss, malabsorption) atypical courses with less or lacking gastrointestinal symptoms exist. The prevalence is about 1 : 100 (Europe, USA) and higher than supposed earlier. Diagnostic criteria include serologic tests (tissue transglutaminase antibody, endomysial antibody) and characteristic small bowel histology (lymphocytic infiltration, villous atrophy). Therapy is a strict and lifelong gluten-free diet. Rarely, refractory disease or lack of compliance are associated with increased risk of malignancy and worse prognosis. Lactose intolerance is attributed to low intestinal lactase levels, due to reduced genetic expression or mucosal injury and consequent intolerance to dairy products. The frequency is varying in different ethnic groups, occurring in 10-15% of Northern European people. Intensity of clinical symptoms (diarrhea, abdominal pain, bloating) depends on the amount of ingested lactose and individual activity of intestinal lactase. The capacity of lactose malabsorption can be measured using the noninvasive lactose breath hydrogen test. The treatment is based on a reduced dietary lactose intake or in case of secondary form treatment of the underlying disease.
乳糜泻和乳糖不耐受都是相对常见的疾病,摄入某些食物成分后会出现症状。在乳糜泻中,小麦麸质和其他谷物的相关蛋白质会在易感个体中引发小肠炎症性疾病,导致胃肠道和肠外症状。此外,它还与许多其他疾病有关,除了典型症状(腹泻、体重减轻、吸收不良)外,还存在胃肠道症状较少或没有的非典型病程。其患病率约为1:100(欧洲、美国),高于此前的推测。诊断标准包括血清学检测(组织转谷氨酰胺酶抗体、肌内膜抗体)和特征性小肠组织学检查(淋巴细胞浸润、绒毛萎缩)。治疗方法是严格且终身的无麸质饮食。极少数情况下,难治性疾病或依从性差与恶性肿瘤风险增加和预后较差有关。乳糖不耐受归因于肠道乳糖酶水平低,这是由于基因表达降低或黏膜损伤以及随之而来的对乳制品不耐受所致。不同种族的发病率各不相同,在北欧人群中为10 - 15%。临床症状(腹泻、腹痛、腹胀)的严重程度取决于摄入乳糖的量和肠道乳糖酶的个体活性。乳糖吸收不良的能力可以通过无创的乳糖呼气氢试验来测量。治疗方法是减少饮食中乳糖的摄入量,或者在继发性乳糖不耐受的情况下治疗潜在疾病。